CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Roche finds another oncology gem in Asia with $1.5B B cell disease partnership

PartnershipPositive
AI Analysis

Summary

Roche entered into a $1.5 billion partnership with Simcere Zaiming to develop a T cell engager for B cell-mediated diseases including lymphoma and autoimmune conditions.

Importance:7/10
Sentiment:
0.70
oncologypartnershipT cell engagerB cell diseaselymphomaautoimmuneAsia
Related Companies

Read the original article

Published by BioSpace on September 1, 2026 3:28 PM

Read Original